NIH-funded research R01 grant

Protecting HIV-Exposed Uninfected Infants from Severe Infections

Official title: Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections

Funded at University of Colorado Denver · NIH-11474445 · Data updated 2026-11-12

A project to help babies born to HIV-positive mothers who are not infected themselves by understanding how their gut bacteria and immune system interact, with the goal of reducing serious infections in the first year or two of life.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startAugust 9, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$17,647
NIH project number3R01HD116631-03S1
Project IDNIH-11474445 on NIH RePORTER

Who could benefit from this research

Could help

Infants who are HIV-exposed but uninfected, from birth through the first year of life, whose families consent to participate.

Less likely to help

Infants who are not HIV-exposed or those unable to participate in longitudinal sampling and follow-up may not benefit.

What this research studies

This research looks at how the gut microbiome influences the developing immune system in HIV-exposed uninfected infants and how this differs from HIV-unexposed infants. The study will compare 50 HEU and 50 HU infants at 6, 24, and 48 weeks, examining immune cell function, gene activity, and metabolites, and linking these findings to gut bacterial communities. Researchers will integrate immunogenomic data with metabolomics to pinpoint metabolites associated with immune dysfunction and test these relationships in the lab. The ultimate aim is to identify dietary or microbial targets that could support healthier immune development in HEU infants. The work is designed to inform future strategies to reduce severe infections in this vulnerable population.

Why it matters

Potential benefit: If successful, the findings could guide dietary or microbiome-based interventions to strengthen immunity and reduce serious infections in HEU infants.

How similar studies have gone: Previous work has shown ties between the microbiome, immune development, and infection risk in early life, making this approach plausible but still exploratory.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Weinberg, Adriana — University of Colorado Denver
  • Study coordinator: Weinberg, Adriana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.